ATSB Comment: The ATSB raised the following concern on behalf of several reporters. Initially focussed on the collection and analysis of data related to COVID-19 vaccines, the scope of the REPCON was broadened to include all approved medication and vaccines.
The ATSB is satisfied that a framework is in place to identify the suitability of medication/vaccines for use in the operational environment and the available guidance clearly defines the guiding principles and considerations when determining the suitability of medications for use by medical certificate holders.
The responsibility for…